Profire Energy (PFIE) Receives Daily News Impact Rating of 0.29

News stories about Profire Energy (NASDAQ:PFIE) have been trending positive on Monday, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Profire Energy earned a media sentiment score of 0.29 on Accern’s scale. Accern also assigned news coverage about the oil and gas company an impact score of 0 out of 100, meaning that recent news coverage is extremely unlikely to have an impact on the company’s share price in the next few days.

Separately, Zacks Investment Research raised Profire Energy from a “hold” rating to a “buy” rating and set a $1.50 price objective on the stock in a research report on Thursday, July 6th.

Profire Energy (PFIE) traded up 2.40% on Monday, reaching $1.28. The company’s stock had a trading volume of 789 shares. The stock has a market cap of $64.28 million, a PE ratio of 58.18 and a beta of 1.68. Profire Energy has a 12-month low of $1.08 and a 12-month high of $1.72. The company’s 50 day moving average price is $1.36 and its 200-day moving average price is $1.34.

In related news, CEO Brenton W. Hatch sold 200,000 shares of Profire Energy stock in a transaction on Thursday, May 25th. The stock was sold at an average price of $1.35, for a total value of $270,000.00. Following the completion of the sale, the chief executive officer now owns 13,850,000 shares of the company’s stock, valued at $18,697,500. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Harold Albert sold 29,315 shares of Profire Energy stock in a transaction on Friday, May 26th. The stock was sold at an average price of $1.46, for a total value of $42,799.90. Following the completion of the sale, the director now directly owns 11,133,040 shares of the company’s stock, valued at approximately $16,254,238.40. The disclosure for this sale can be found here. In the last three months, insiders sold 381,022 shares of company stock valued at $510,819. Corporate insiders own 51.10% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Profire Energy (PFIE) Receives Daily News Impact Rating of 0.29” was first posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this story on another site, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be read at https://www.tickerreport.com/banking-finance/2722459/profire-energy-pfie-receives-daily-news-impact-rating-of-0-29.html.

Profire Energy Company Profile

Profire Energy, Inc is an oilfield technology company. The Company is primarily engaged in the business of developing combustion management technologies for the oil and gas industry. It specializes in the creation of burner-management systems, used on a range of oilfield natural-draft fire tube vessels.

Insider Buying and Selling by Quarter for Profire Energy (NASDAQ:PFIE)

Receive News & Ratings for Profire Energy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Profire Energy Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
Shares at Radius Jump as Bone Drug of Amgen Has Setback
Shares at Radius Jump as Bone Drug of Amgen Has Setback


Leave a Reply

© 2006-2017 Ticker Report. Google+.